Oral recombinant Helicobacter pylori vaccine (E. coli) (Olymvax Biopharmaceuticals)
口服重组幽门螺杆菌疫苗（大肠杆菌）（成都欧林生物科技）
Report date: 2025/11/06 17:01:30
Base Information
Drug NameOral recombinant Helicobacter pylori vaccine (E. coli) (Olymvax Biopharmaceuticals)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChengdu Oulin Biological Science & Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChengdu Oulin Biological Science & Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A